-
5th May 2019, 07:11 PM
#1
The protocol needs to be followed otherwise, by definition, there is a protocol deviation. If you need longer windows then this should be included in an amendment.
Whether of not the subsequent protocol deviations are deemed to be "significant" from a subject welfare or data integrity perspective should then be determined by the project team, including the Medical Monitor, Clinical Scientist and Statistician.
-
14th Jun 2019, 07:46 PM
#2
ICH has an excellent document ICH E3
EMA/CHMP/ICH/435606/2012
Committee for medicinal products human use (CHMP)
ICH guideline E3 - questions and answers (R1)
Step 5. July 2012
Q; What is the distinction between a protocol deviation, important protocol deviation, and a protocol violation?
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules